Mathilde Cabart
Impact in
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 2
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 4
- Prostate Cancer Treatment and Research 3
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Guilhem Roubaud (8 shared papers)Paul Sargos (2 shared papers)Isabelle Soubeyran (1 shared paper)Nicolas Sévenet (1 shared paper)Henri Margot (1 shared paper)Sophie Cousin (7 shared papers)François Chomy (6 shared papers)Jean Palussière (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (4 papers)Clinical Cancer Research (2 papers)Journal of Geriatric Oncology (2 papers)Acta Oncologica (1 paper)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Mathilde Cabart
19 papers receiving 273 citations
Peers
Comparison fields: 5 of 48
- Oncology 108
- Pulmonary and Respiratory Medicine 106
- Biological Psychiatry 6
- Hepatology 15
- Cancer Research 26
Countries citing papers authored by Mathilde Cabart
This map shows the geographic impact of Mathilde Cabart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Cabart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Cabart more than expected).
Fields of papers citing papers by Mathilde Cabart
This network shows the impact of papers produced by Mathilde Cabart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Cabart. The network helps show where Mathilde Cabart may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathilde Cabart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | 2022 | 31 | |
| 3 | 2023 | 28 | |
| 4 | 2019 | 18 | |
| 5 | 2017 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 13 | |
| 8 | 2024 | 13 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 8 | |
| 11 | 2016 | 8 | |
| 12 | 2016 | 4 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Mathilde Cabart
Mathilde Cabart is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 21 papers that have together received 277 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (4 papers), Prostate Cancer Treatment and Research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), PARP inhibition in cancer therapy (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Oncology (108 citations), Pulmonary and Respiratory Medicine (106 citations), Biological Psychiatry (6 citations), Hepatology (15 citations) and Cancer Research (26 citations). Mathilde Cabart has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Guilhem Roubaud, Paul Sargos, Isabelle Soubeyran, Nicolas Sévenet, Henri Margot, Sophie Cousin, François Chomy, Jean Palussière, Alban Bessede and Xavier Buy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Journal of Geriatric Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.